NVIDIA To $240? Here Are 5 Other Price Target Changes For Tuesday

  • Raymond James cut the price target on NVIDIA Corporation NVDA from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to $172.92 in pre-market trading.
  • Piper Sandler boosted monday.com Ltd. MNDY price target from $150 to $180. However, Piper Sandler analyst Brent Bracelin maintained an Overweight rating on the stock. monday.com shares fell 1.8% to $147.77 in pre-market trading.
  • Wells Fargo cut Tandem Diabetes Care, Inc. TNDM price target from $82 to $49. Wells Fargo analyst Larry Biegelsen also downgraded the stock from Overweight to Underweight. Tandem Diabetes Care shares fell 2% to $58.90 in pre-market trading.
  • BMO Capital raised Brunswick Corporation BC price target from $90 to $110. BMO Capital analyst Gerrick Johnson upgraded the stock from Market Perform to Outperform. Brunswick shares rose 1.4% to $81.08 in pre-market trading.
  • HC Wainwright & Co. raised ACADIA Pharmaceuticals Inc. ACAD price target from $20 to $25. However, HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating on the stock. ACADIA Pharmaceuticals rose 1.1% to close at $16.62 on Monday.
  • Chardan Capital cut CRISPR Therapeutics AG CRSP price target from $164 to $154. However, Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. CRISPR Therapeutics shares dropped 2.6% to $79.30 in pre-market trading.

Check out this: Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: NewsPrice TargetPre-Market OutlookMarketsAnalyst RatingsPrice Target Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!